Results 191 to 200 of about 198,800 (341)

Integrative Transcriptomic and Network-Based Analysis of Neuromuscular Diseases. [PDF]

Int J Mol Sci
García-Criado F, Hurtado-García L, Rojano E, Esteban-Martos Á, Pérez-García J, Seoane P, Ranea JAG.   +6 more
europepmc   +1 more source

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles

Annals of Neurology, EarlyView.
Objective Identifying modifiable factors influencing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) risk is important for prevention. Blood biomarkers, particularly cholesterol, have been associated with neurodegenerative risk, but findings in ALS are inconsistent, and data on FTD are limited.
Christos V. Chalitsios, Jiali Gao, Carol A.C. Coupland, Julia Hippisley Cox, Martin R. Turner, Alexander G. Thompson   +5 more
wiley   +1 more source

SYSTEMATIC REVIEWS TO HELP GUIDE CLINICAL PRACTICE IN NEUROMUSCULAR DISEASE [PDF]

, 2003
Kate Jewitt, Richard AC Hughes
openalex   +1 more source

Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases. [PDF]

Int J Mol Sci
Akyürek EE, Erba M, Dalla Barba F, Sandonà D, Sacchetto R.   +4 more
europepmc   +1 more source

Rehabilitation Interventions Delivered via Telehealth to Support Self‐Management of Rheumatic and Musculoskeletal Disease: A Scoping Review

Arthritis &Rheumatology, EarlyView.
Objective To identify and summarize existing telerehabilitation interventions for people living with rheumatic and musculoskeletal diseases (RMDs), including the rehabilitation components, the technology used, the type of health care professional (HCP) interaction, and how the effectiveness is evaluated.
Thomas A. Ingram, Rosemarie Barnett, Nuzhat Shakaib, Simon Jones, Raj Sengupta, Peter C. Rouse   +5 more
wiley   +1 more source

Automated Classification of Neuromuscular Diseases Using Thigh Muscle MRI With Model Interpretations. [PDF]

J Cachexia Sarcopenia Muscle
Huysmans L, Iterbeke L, De Wel B, Opsomer M, Claeys KG, Maes F.   +5 more
europepmc   +1 more source

Differential diagnosis of hypokinetic disorders in hereditary neuromuscular diseases

, 1997
Л А Сайкова, В Д Косачев, В. Г. Пустозеров, Т. М. Алексеева, Tatyana Vasilyeva, I. G. Zavolokov   +5 more
openalex   +2 more sources

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR). [PDF]

Eur J Neurol
Dumas R, Jannot AS, Elarouci N, Salort-Campana E, Pisella L, Tard C, Sacconi S, Bouhour F, Sarrazin E, Spinazzi M, Laforet P, Pereon Y, Nadaj-Pakleza A, Echaniz-Laguna A, Choumert A, Magy L, Feasson L, Esselin F, Cances C, Espile C, Desguerre I, Rouzier C, Cintas P, Stojkovic T, Solé G, Attarian S, FILNEMUS Study Group.   +26 more
europepmc   +1 more source

Outcome of children with neuromuscular disease admitted to paediatric intensive care [PDF]

, 2004
Kylie Yates
openalex   +1 more source